Biontech Se ADR (BNTX)

1 · Reply

___dog___ Apr. 29 at 4:28 AM

$BNTX yes actually that's how I got my first monies to trade.

0 · Reply

htw7448 Apr. 29 at 4:22 AM

$BNTX is your second job clown?

0 · Reply

___dog___ Apr. 28 at 9:34 PM

0 · Reply

___dog___ Apr. 28 at 9:33 PM

$BNTX Were going to turn some screws tomorrow. Just getting started

0 · Reply

htw7448 Apr. 28 at 7:23 PM

$BNTX just compressed information about all P3 drugs 2026-05 BNT323 Breast Cancer https://clinicaltrials.gov/study/NCT06018337 2027-01 BNT327 2L-small-cell lung cancer (ORPHAN STATUS) https://clinicaltrials.gov/study/NCT06616532 2027-07 BNT327 triple negative breast cancer https://clinicaltrials.gov/study/NCT06419621 2027-08 BNT316 non small lung cancer (FAST TRACK) https://clinicaltrials.gov/study/NCT05671510 2028-03 BNT323 Uterine Cancer https://clinicaltrials.gov/study/NCT06340568 2028-12 BNT327 1L-small-cell lung cancer(ORPHAN STATUS) https://clinicaltrials.gov/study/NCT06712355 10 P2 drugs are in transition to P3 this year. If i find time i could post P2/3 drugs too.

0 · Reply

htw7448 Apr. 28 at 5:44 PM

$BNTX next important days: - 5 th may annual report and pipeline update - 5 th may is also the official p3 readout date for their BNT327, one of many trials for several tumor types - so this result will guiding. - some of their drugs are such game changers that its very likely that they will get very fast into the market.

1 · Reply

htw7448 Apr. 28 at 5:31 PM

1 · Reply

___dog___ Apr. 28 at 5:27 PM

0 · Reply

htw7448 Apr. 28 at 3:59 PM

$BNTX 😂, KI generated answers … . The important information is not visible but your own bias forming the answers. Sit doen or try again.

0 · Reply

Two experimental drugs showed striking early results against pancreatic cancer

RVMD

Apr 21, 2026, 6:45 AM EDT - 8 days ago

BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026

Apr 11, 2026, 7:00 AM EDT - 18 days ago

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

Apr 1, 2026, 11:39 AM EDT - 4 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Mar 24, 2026, 6:45 AM EDT - 5 weeks ago

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

Mar 10, 2026, 3:39 PM EDT - 7 weeks ago

BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls

Mar 10, 2026, 2:48 PM EDT - 7 weeks ago

BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 10, 2026, 1:29 PM EDT - 7 weeks ago

One simple reason why BioNTech stock is a raging buy on today's crash

Mar 10, 2026, 8:40 AM EDT - 7 weeks ago

BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

Mar 10, 2026, 8:00 AM EDT - 7 weeks ago

BioNTech SE Earnings Call Transcript: Q4 2025

Mar 10, 2026, 7:40 AM EDT - 7 weeks ago

Scientists behind COVID-19 vaccine will depart BioNTech

Mar 10, 2026, 7:18 AM EDT - 7 weeks ago

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock.

Mar 10, 2026, 6:50 AM EDT - 7 weeks ago

BioNTech Cofounders to Leave to Form New Company

Mar 10, 2026, 6:49 AM EDT - 7 weeks ago

BioNTech's founding couple Sahin, Tuereci to leave to set up new venture

Mar 10, 2026, 6:45 AM EDT - 7 weeks ago

BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

Mar 10, 2026, 6:33 AM EDT - 7 weeks ago

BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030

Feb 24, 2026, 6:45 AM EST - 2 months ago

BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026

Feb 19, 2026, 1:25 PM EST - 2 months ago

BioNTech sues Moderna for patent infringement over COVID-19 shots

MRNA

Jan 28, 2026, 8:00 AM EST - 3 months ago

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

Jan 13, 2026, 5:15 PM EST - 3 months ago

BioNTech SE Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 6:45 AM EST - 3 months ago

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 10:00 AM EST - 3 months ago

University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

Dec 18, 2025, 4:45 AM EST - 4 months ago

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

Dec 9, 2025, 7:00 AM EST - 5 months ago

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

Dec 6, 2025, 3:30 PM EST - 5 months ago

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Dec 3, 2025, 9:01 AM EST - 5 months ago

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

CVAC

Dec 1, 2025, 3:50 PM EST - 5 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

MRNA NVAX PFE

Dec 1, 2025, 12:35 PM EST - 5 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

MRNA NVAX PFE

Nov 26, 2025, 7:30 AM EST - 5 months ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Nov 13, 2025, 5:20 PM EST - 5 months ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 11:10 AM EST - 5 months ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Nov 13, 2025, 8:17 AM EST - 5 months ago

BioNTech says collaboration with Pfizer remains unchanged

Nov 11, 2025, 9:00 AM EST - 6 months ago

BioNTech SE Transcript: R&D Day

Nov 3, 2025, 10:29 AM EST - 6 months ago

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

Nov 3, 2025, 8:00 AM EST - 6 months ago

BioNTech SE Earnings Call Transcript: Q3 2025

Nov 3, 2025, 6:47 AM EST - 6 months ago

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Nov 3, 2025, 6:45 AM EST - 6 months ago

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Oct 28, 2025, 7:45 AM EDT - 6 months ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 27, 2025, 7:45 AM EDT - 6 months ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 22, 2025, 6:45 AM EDT - 6 months ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 1, 2025, 9:00 AM EDT - 7 months ago

BioNTech SE Transcript: AI Day 2025

Sep 23, 2025, 6:45 AM EDT - 7 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 19, 2025, 11:40 AM EDT - 7 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

Sep 12, 2025, 1:37 PM EDT - 8 months ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

Sep 8, 2025, 2:01 PM EDT - 8 months ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

Sep 8, 2025, 11:05 AM EDT - 8 months ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

Sep 8, 2025, 11:00 AM EDT - 8 months ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 7:02 AM EDT - 8 months ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

Sep 8, 2025, 6:45 AM EDT - 8 months ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Sep 5, 2025, 5:13 AM EDT - 8 months ago

BioNTech, Duality score initial trial win with breast cancer precision drug

Aug 27, 2025, 12:50 PM EDT - 8 months ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Aug 7, 2025, 9:00 PM EDT - 9 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

Aug 5, 2025, 1:36 PM EDT - 9 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 4, 2025, 10:32 AM EDT - 9 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 8:00 AM EDT - 9 months ago

BioNTech SE Earnings Call Transcript: Q2 2025

Aug 4, 2025, 7:01 AM EDT - 9 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

May 16, 2025, 8:00 AM EDT - 1 year ago

BioNTech SE Transcript: AGM 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

BioNTech SE Earnings Call Transcript: Q1 2025

Mar 10, 2025, 8:00 AM EDT - 1 year ago

BioNTech SE Earnings Call Transcript: Q4 2024

Jan 14, 2025, 12:00 PM EST - 1 year ago

BioNTech SE Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Nov 14, 2024, 10:30 AM EST - 1 year ago

BioNTech SE Transcript: R&D Day 2024

Nov 4, 2024, 8:00 AM EST - 1 year ago

BioNTech SE Earnings Call Transcript: Q3 2024

Oct 1, 2024, 9:00 AM EDT - 1 year ago

BioNTech SE Transcript: AI Day 2024

Aug 5, 2024, 8:00 AM EDT - 1 year ago

BioNTech SE Earnings Call Transcript: Q2 2024

May 6, 2024, 8:00 AM EDT - 2 years ago

BioNTech SE Earnings Call Transcript: Q1 2024

Mar 20, 2024, 8:00 AM EDT - 2 years ago

BioNTech SE Earnings Call Transcript: Q4 2023

Jan 9, 2024, 12:00 PM EST - 2 years ago

BioNTech SE Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Dec 18, 2023, 8:00 AM EST - 2 years ago

BioNTech SE Transcript: Status Update

Nov 7, 2023, 9:00 AM EST - 2 years ago

BioNTech SE Transcript: Innovation Series Day 2023

Nov 6, 2023, 8:00 AM EST - 2 years ago

BioNTech SE Earnings Call Transcript: Q3 2023

Aug 7, 2023, 8:00 AM EDT - 2 years ago

BioNTech SE Earnings Call Transcript: Q2 2023

May 8, 2023, 8:00 AM EDT - 3 years ago

BioNTech SE Earnings Call Transcript: Q1 2023

Mar 27, 2023, 8:00 AM EDT - 3 years ago

BioNTech SE Earnings Call Transcript: Q4 2022

Nov 7, 2022, 8:00 AM EST - 3 years ago

BioNTech SE Earnings Call Transcript: Q3 2022

Aug 8, 2022, 10:37 AM EDT - 4 years ago

BioNTech SE Earnings Call Transcript: Q2 2022

Jun 29, 2022, 8:00 AM EDT - 4 years ago

BioNTech SE Transcript: Innovation Series Day 2022

May 9, 2022, 10:36 AM EDT - 4 years ago

BioNTech SE Earnings Call Transcript: Q1 2022

Mar 29, 2022, 8:00 PM EDT - 4 years ago

BioNTech SE Earnings Call Transcript: Q4 2021

Dec 8, 2021, 9:00 AM EST - 4 years ago

BioNTech SE Transcript: Study Update

Nov 8, 2021, 7:00 PM EST - 4 years ago

BioNTech SE Earnings Call Transcript: Q3 2021

Aug 9, 2021, 7:00 AM EDT - 5 years ago

BioNTech SE Earnings Call Transcript: Q2 2021

May 10, 2021, 12:35 PM EDT - 5 years ago

BioNTech SE Earnings Call Transcript: Q1 2021

Mar 30, 2021, 3:32 AM EDT - 5 years ago

BioNTech SE Earnings Call Transcript: Q4 2020

Nov 10, 2020, 10:56 AM EST - 5 years ago

BioNTech SE Earnings Call Transcript: Q3 2020

Aug 11, 2020, 8:00 AM EDT - 6 years ago

BioNTech SE Earnings Call Transcript: Q2 2020

Jul 1, 2020, 11:00 AM EDT - 6 years ago

BioNTech SE Transcript: Study Result

May 12, 2020, 8:00 AM EDT - 6 years ago

BioNTech SE Earnings Call Transcript: Q1 2020

___dog___ Apr. 29 at 4:29 AM

1 · Reply

___dog___ Apr. 29 at 4:28 AM

$BNTX yes actually that's how I got my first monies to trade.

0 · Reply

htw7448 Apr. 29 at 4:22 AM

$BNTX is your second job clown?

0 · Reply

___dog___ Apr. 28 at 9:34 PM

0 · Reply

___dog___ Apr. 28 at 9:33 PM

$BNTX Were going to turn some screws tomorrow. Just getting started

0 · Reply

htw7448 Apr. 28 at 7:23 PM

0 · Reply

htw7448 Apr. 28 at 5:44 PM

1 · Reply

htw7448 Apr. 28 at 5:31 PM

1 · Reply

___dog___ Apr. 28 at 5:27 PM

0 · Reply

htw7448 Apr. 28 at 3:59 PM

$BNTX 😂, KI generated answers … . The important information is not visible but your own bias forming the answers. Sit doen or try again.

0 · Reply

___dog___ Apr. 28 at 3:45 PM

$BNTX let's get that 80 area

0 · Reply

___dog___ Apr. 28 at 3:08 PM

$BNTX not until I'm done with it

1 · Reply

___dog___ Apr. 28 at 3:07 PM

$BNTX yes they are planning for their taxes

0 · Reply

___dog___ Apr. 28 at 3:01 PM

$BNTX 80 should be good

1 · Reply

taxplanr Apr. 28 at 2:52 PM

$BNTX insiders have a preferred selling range

0 · Reply

GiladF Apr. 28 at 12:12 PM

$BNTX I still say this pumps after announcements but shares are the safest play.

1 · Reply

SuperGreenToday Apr. 28 at 8:12 AM

$BNTX Share Price: $102.10 Contract Selected: Sep 18, 2026 $100 Calls Buy Zone: $16.20 – $20.02 Target Zone: $26.86 – $32.83 Potential Upside: 57% ROI Time to Expiration: 142 Days | Updates via https://fxcapta.com/stockinfo/

1 · Reply

___dog___ Apr. 28 at 3:16 AM

$BNTX yes it's a goner

0 · Reply

Lambo2 Apr. 28 at 1:54 AM